Impaired immunogenicity of BNT162b2 anti-SARS-CoV-2 vaccine in patients treated for solid tumors
Jérôme Barrière, Emmanuel Chamorey, Zoubir Adjtoutah, O. Castelnau, Aba Mahamat, S. Di Marco, Emmanuel Petit, A. Leysalle, V. Raimondi, Michel Carlès
Topics & Concepts
MedicineVaccinationImmunogenicityBooster doseFamily medicinePopulationCancerInternal medicinePediatricsOncologyImmunologyImmunizationImmune systemEnvironmental healthSARS-CoV-2 and COVID-19 ResearchHepatitis B Virus StudiesCancer Immunotherapy and Biomarkers